Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Illinois at Chicago
Study ID
NCT07014111
Status
Recruiting
Apply to this trial

Conditions

  • End Stage Renal Disease on Dialysis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Fight Fatigue — BEHAVIORAL
    Combined progressive muscle relaxation and walking (increasing step count) 12-week intervention that consists of education/training followed by text messages.
  • Attention Control — OTHER
    End-stage kidney disease education

Study Details

Fight Fatigue is evaluating the feasibility and acceptability of a combined progressive muscle relaxation and walking intervention to reduce fatigue for adults with end-stage kidney disease receiving in-center hemodialysis.

Key Dates

Start date
Sep 2, 2025
Status verified
Jun 2025
Primary completion
Feb 28, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Fight Fatigue
    Combined progressive muscle relaxation and walking (increasing step count) 12-week intervention that consists of education/training followed by text messages
  • Active Comparator: Attention Control
    End-stage kidney disease education, followed by text messages (over 12 weeks)

Primary Outcome Measure

Feasibility of recruitment [ Time Frame: Baseline to week 12 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UI Health/University of Illinois ChicagoChicagoIllinois60612
Mary Hannan
[email protected]
312-355-4838

Find similar trials in Chicago, IL

By research site
UI Health/University of Illinois Chicago· Chicago, IL

Related Studies